Ralph Pannell

2.8k total citations
44 papers, 2.3k citations indexed

About

Ralph Pannell is a scholar working on Cancer Research, Hematology and Biotechnology. According to data from OpenAlex, Ralph Pannell has authored 44 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 20 papers in Hematology and 14 papers in Biotechnology. Recurrent topics in Ralph Pannell's work include Protease and Inhibitor Mechanisms (22 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers) and Enzyme Production and Characterization (13 papers). Ralph Pannell is often cited by papers focused on Protease and Inhibitor Mechanisms (22 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers) and Enzyme Production and Characterization (13 papers). Ralph Pannell collaborates with scholars based in United States, France and Pakistan. Ralph Pannell's co-authors include James Travis, Victor Gurewich, David A. Johnson, Jean Bowen, Duane A. Tewksbury, Shirley C. Louie, Robert L. Suddith, J Black, Michael T. Johnstone and Lauren Wood and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Ralph Pannell

42 papers receiving 2.1k citations

Peers

Countries citing papers authored by Ralph Pannell

Since Specialization

Citations

This map shows the geographic impact of Ralph Pannell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Pannell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Pannell more than expected).

Fields of papers citing papers by Ralph Pannell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Pannell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Pannell. The network helps show where Ralph Pannell may publish in the future.

Co-authorship network of co-authors of Ralph Pannell

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Pannell. A scholar is included among the top collaborators of Ralph Pannell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Pannell. Ralph Pannell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination 2017 ·Journal of Thrombosis and Thrombolysis ·Ralph Pannell, (unknown), Victor Gurewich	9
2	Highly Effective Fibrinolysis by a Sequential Synergistic Combination of Mini-Dose tPA plus Low-Dose Mutant proUK 2015 ·PLoS ONE ·Ralph Pannell, (unknown), Victor Gurewich	12
3	Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis 2009 ·Thrombosis and Haemostasis ·Ralph Pannell, Victor Gurewich	8
4	C1‐inhibitor prevents non‐specific plasminogen activation by a prourokinase mutant without impeding fibrin‐specific fibrinolysis 2007 ·Journal of Thrombosis and Haemostasis ·Ralph Pannell, (unknown), Victor Gurewich	12
5	Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro 2007 ·Blood ·Romaric Lacroix, Florence Sabatier, Agnès Mialhe, Agnès Basire, Ralph Pannell, (unknown), Stéphane Robert, (unknown), Laurent Plawinski, Laurence Camoin‐Jau, Victor Gurewich, Eduardo Anglés‐Cano, Françoise Dignat‐George	164
6	Thrombolysis vs. bleeding from hemostatic sites by a prourokinase mutant compared with tissue plasminogen activator 2006 ·Journal of Thrombosis and Haemostasis ·Victor Gurewich, Ralph Pannell, (unknown), Paolo Sarmientos, (unknown), Stephen F. Badylak	14
7	An Efficient System for Production of Recombinant Urokinase-Type Plasminogen Activator 1997 ·Protein Expression and Purification ·Wei Tang, Ziyong Sun, Ralph Pannell, Victor Gurewich, (unknown)	24
8	Platelet-Bound Prekallikrein Promotes Pro-Urokinase-Induced Clot Lysis: A Mechanism for Targeting the Factor XII Dependent Intrinsic Pathway of Fibrinolysis 1994 ·Thrombosis and Haemostasis ·(unknown), Victor Gurewich, Michael T. Johnstone, Ralph Pannell	37
9	Lipoprotein(a): A kinetic study of its influence on fibrin-dependent plasminogen activation by prourokinase or tissue plasminogen activator 1993 ·Biochemistry ·Jian Ning Liu, Peter C. Harpel, Ralph Pannell, Victor Gurewich	14
10	Pro‐urokinase and prekallikrein are both associated with platelets 1993 ·FEBS Letters ·Victor Gurewich, Michael T. Johnstone, (unknown), Ralph Pannell	38
11	The Intrinsic Lysis Concepta 1992 ·Annals of the New York Academy of Sciences ·Victor Gurewich, Jian‐Ning Liu, Ralph Pannell	11
12	The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation 1991 ·Thrombosis Research ·(unknown), Ralph Pannell, Victor Gurewich	12
13	Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. 1990 ·Journal of Biological Chemistry ·Roy L. Silverstein, Ralph L. Nachman, Ralph Pannell, Victor Gurewich, P C Harpel	39
14	Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158). 1988 ·Journal of Clinical Investigation ·Victor Gurewich, Ralph Pannell, R. Broeze, Jen-i Mao	34
15	Fibrin activatable urokinase (FA-UK): A latent form of UK found in urine related to a complex with an inhibitor/fibrin-interacting cofactor 1988 ·Thrombosis Research ·(unknown), Ralph Pannell, Victor Gurewich	2
16	Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. 1988 ·Journal of Clinical Investigation ·Ralph Pannell, J Black, Victor Gurewich	113
17	Fibrin Binding and Zymogenic Properties of Single-Chain Urokinase (Pro-urokinase) 1987 ·Seminars in Thrombosis and Hemostasis ·Victor Gurewich, Ralph Pannell	9
18	Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. 1984 ·Journal of Clinical Investigation ·Victor Gurewich, Ralph Pannell, Shirley C. Louie, (unknown), Robert L. Suddith, (unknown)	238
19	Chromatography of non-human albumins on Cibacron Blue—agarose 1979 ·Journal of Chromatography A ·Philip C. Kelleher, Carol J. Smith, Ralph Pannell	18
20	The molecular stoichiometry of trypsin inhibition by human alpha-1-proteinase inhibitor 1974 ·Biochemical and Biophysical Research Communications ·David A. Johnson, Ralph Pannell, James Travis	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact